Friday, November 04, 2016 7:23:51 AM
Reading the recent posts gives me a "deja vu" of the Yahoo MB .... I think we have to put into perspective the following:
1.- Its only been 4 months since Probuphine was approved and its been in the market 3 1/2 months... a pill would not have had a quicker introduction. On this point dont forget that pills get sold in monthly packets (normally) and Probu gets sold as a 6 month treatment so it would be fair to multiply every Probu pack times six..I say this for when the sales results get published so people dont go running for the corners because of the low number of sales
2.- New Tech requires time to be adopted by both users and prescribers, we are at the very beginning of a new way to treat illness and this will take time, period. How long? its anybody´s guess but the Zacks analyst did give some sales numbers that just might be right at least for the fist few quarters
3.- Have any of you checked out what the Bio tech sector is doing over the last 2 weeks??? please check it and compare it with TTNP you will see we haven´t faired better or worse.
4.- The 4th Quarter is not even half way and there are some that want to see the results upfront... well they did say 4th Q so lets be patient and come January if they have not delivered then vent all you want.
5.- A rising SP will only happen if the sales results come in and this will only happen if the right agreements are put in place with the insurers (which Braeburn has said its doing right now); if the sales & distribution partner for the Rest of the World is signed (Sunil did say they are talking to a few of those and that early 2017 should be closing time for this (if I remember correctly)
6.- Rest of products in development where kicked off seriously once Probuphine was approved and the 15Mill received so lets be patient and see how the management delivers in Q4 and Q1 as they have already said so in previous CCs
These are some of my thoughts....
So, guys, be patient or get out, please don´t mess this MB up like some already did with the Yahoo one. Don´t vent your vile here, this place is to share well documented info and even share your thoughts, positive or negative, but not the s h i t - h o le where everybody comes to throw up.
Thanks
EMA
Recent TTNP News
- Form 8-K - Current report • Edgar (US Regulatory) • 01/25/2024 09:33:11 PM
- Titan Pharmaceuticals Fully Compliant With NASDAQ Listing Criteria • GlobeNewswire Inc. • 01/25/2024 09:29:23 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/18/2024 09:59:05 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/08/2024 10:13:45 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/28/2023 09:30:20 PM
- Titan Pharmaceuticals Announces Reverse Stock Split and Ratio • GlobeNewswire Inc. • 12/28/2023 09:15:00 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 11/28/2023 09:47:46 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 11/17/2023 09:03:19 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/15/2023 09:05:15 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 10/26/2023 08:33:07 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 10/26/2023 08:31:25 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 10/26/2023 08:29:31 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 10/26/2023 08:25:57 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 10/26/2023 08:23:37 PM
- Form S-8 - Securities to be offered to employees in employee benefit plans • Edgar (US Regulatory) • 10/24/2023 09:26:34 PM
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 10/23/2023 07:07:26 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/16/2023 09:08:35 PM
- Titan Pharmaceuticals Announces Appointment of Dato' Seow Gim Shen and Brynner Chaim to the Company's Board of Directors • GlobeNewswire Inc. • 10/16/2023 08:37:23 PM
- Form SC 13D - General statement of acquisition of beneficial ownership • Edgar (US Regulatory) • 10/04/2023 09:30:18 PM
- Form 8-K/A - Current report: [Amend] • Edgar (US Regulatory) • 09/19/2023 08:41:40 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/18/2023 08:45:22 PM
- Titan Pharmaceuticals Announces $9.5 Million Private Placement of Convertible Preferred Stock • GlobeNewswire Inc. • 09/18/2023 11:30:00 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/08/2023 09:30:03 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/30/2023 08:28:25 PM
FEATURED DaBaby and Stunna 4 Vegas's "NO DRIBBLE" Joins Music Licensing, Inc.'s Portfolio • Jun 7, 2024 10:15 AM
Mushrooms Inc. (OTC: MSRM) Announces Significant Share Buy Back by the Board Director and New Strategic Initiatives. • MSRM • Jun 5, 2024 1:32 PM
Hydromer Announces Launch of HydroThrombX Medical Device Coating Technology • HYDI • Jun 5, 2024 10:24 AM
Dr. Michael Dent Finances $1 Million to Drive HealthLynked's Healthcare Transformation • HLYK • Jun 5, 2024 8:00 AM
Avant Technologies Enters Binding LOI to Purchase Dozens of High-Performance, Immersible, AI-Powered Servers • AVAI • Jun 5, 2024 8:00 AM
IQST - iQSTEL Announces $290 Million 2024 Annual Revenue Forecast • IQST • Jun 4, 2024 1:43 PM